A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient


Yilmaz R., Akoglu H. , Yirkpantur A., Kilickap S. , Arici M. , Altun B. , ...More

RENAL FAILURE, vol.29, no.1, pp.103-105, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1080/08860220601039528
  • Title of Journal : RENAL FAILURE
  • Page Numbers: pp.103-105

Abstract

Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.